CANCER TEST
HEREDITARY CANCER & PREDISPOSITION
HereditArray
Information
Questions
Turn Around Time:
HereditArray: up to 3 weeks*
* The test is performed at microDiagnostics’ Ltd facilities, with Next Generation Sequencing (NGS)
I Choose HereditArray
With HereditArray we focus on the BRCA1 & BRCA2 genes , whose mutations have been inextricably linked to the occurrence of hereditary breast, ovarian, prostate, and pancreatic cancer. HereditArray analyzes an additional 33 genes, thus offering a comprehensive view of the degree of genetic predisposition to the occurrence of the following cancers: breast, ovarian, prostate, pancreatic, colorectal, stomach, and melanoma.
The genetic syndromes associated with the above cancers and which can be served by the HereditArray test are the following:
Fanconi anemia
Ataxia telangiectasia (Louis-Bar syndrome)
Diffuse type of gastric cancer
Hereditary breast-ovarian cancer (HBOC)
Lymphangioleiomyomatosis
Neurofibromatosis type 2
Tuberous sclerosis
Familial adenomatous polyposis (FAP and AFAP)
Paraganglioma
Multiple endocrine neoplasia type 1 and type 2
MUTYH-associated polyposis
Nijmegen breakage syndrome
Juvenile polyposis syndrome
Familial melanoma and atypical nevi
BAP1-associated tumor predisposition syndrome
Bannayan-Ruvalcaba-Riley syndrome
Cowden syndrome
Li-Fraumeni syndrome
Lynch syndrome
Peutz-Jeghers syndrome
PPAP syndrome
Proteus syndrome
Von Hippel-Lindau syndrome
Pheochromocytoma
Consult your Oncologist for the best choice and personalization for you.
Mutations in the tumor suppressor genes BRCA1 & BRCA2 account for a large number of hereditary cancer cases, but it is known that there are other genes whose mutation is closely associated with carcinogenesis. HereditArray was developed as a method to identify genetic mutations associated with hereditary cancers of the breast, ovary, prostate, pancreas, colon, stomach and melanoma.
The aim is prevention and early diagnosis in the initial and more curable stages of the disease. The test can also help in choosing a treatment regimen and inform members of the wider family about the risk of developing cancer.
A small amount of blood (~10 ml) is taken, as in a routine hematology test. In the event that the blood collection is not performed at Microdiagnostics facilities, the blood should be collected in a 10ml EDTA blood collection vial.
Transport conditions: The vial with the blood is kept at refrigerator temperature (preservation) and after collection, it is recommended to be transported at Microdiagnostics facilities as soon as possible.
Contact us immediately to arrange for its safe and rapid transport to our laboratory. You will also need to quickly and easily complete the Consent Form.
Frequently Asked Questions (FAQ)
Mutations in the tumor suppressor genes BRCA1 & BRCA2 account for a large number of hereditary cancer cases, but it is known that there are other genes whose mutation is closely associated with carcinogenesis. HereditArray was developed as a method to identify genetic mutations associated with hereditary cancers of the breast, ovary, prostate, pancreas, colon, stomach and melanoma.
The aim is prevention and early diagnosis in the initial and more curable stages of the disease. The test can also help in choosing a treatment regimen and inform members of the wider family about the risk of developing cancer.
A small amount of blood (~ 10 ml) is obtained, as in a routine blood test. In case you do not make the donation in the premises of microDiagnostics Ltd by appointment, blood should be collected in general blood vial containing EDTA 10ml.
Transport Conditions: The vial with blood is kept at refrigerator temperature (conservation) and is recommended to be transported to the MicroDiagnostics Ltdfacility as soon as possible.
If the blood sample is not taken at Microdiagnostics facilities, contact us immediately at 2310 23 22 72 and we will arrange for the sample to be transported to our laboratory.
by credit/debit card, bank deposit or online interbank deposit
One of the primary concerns of microDiagnostics’ Ltd is the protection of your personal data as well as the strict adherence to the conditions protecting your genetic material and medical results.
In full compliance with the General Data Protection Regulation (GDPR) we ensure that you are aware and conscious for any examination will be conducted and we do not announce results via phone calls.